Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
The antiviral effects of a MEK1/2 inhibitor promote tumor regression in a preclinical model of human papillomavirus infection-induced tumorigenesis.
Antiviral Res. 2023 Aug;216:105667. doi: 10.1016/j.antiviral.2023.105667. Epub 2023 Jul 8.
Antiviral Res. 2023.
PMID: 37429527
Free article.
MEK/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors.
Luna AJ, Sterk RT, Griego-Fisher AM, Chung JY, Berggren KL, Bondu V, Barraza-Flores P, Cowan AT, Gan GN, Yilmaz E, Cho H, Kim JH, Hewitt SM, Bauman JE, Ozbun MA.
Luna AJ, et al.
PLoS Pathog. 2021 Jan 22;17(1):e1009216. doi: 10.1371/journal.ppat.1009216. eCollection 2021 Jan.
PLoS Pathog. 2021.
PMID: 33481911
Free PMC article.
Item in Clipboard
Cite
Cite